engraftment
Showing 1 - 25 of 1,829
Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)
Recruiting
- Leukemia
- +2 more
- applying of FLU+CY post-HSCT
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Nov 23, 2023
Stem Cells Mobilization, colLection and Engraftment in Newly
Recruiting
- Multiple Myeloma
- +3 more
-
Rome, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023
Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )
Recruiting
- Hematological Disease
- Allogeneic Hematopoietic Stem Cell Transplantation
- Hetrombopag
- placebo
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Feb 6, 2023
Bone Marrow Transplant Complications, Fatigue, Vital Signs Trial in Ankara (Reiki)
Recruiting
- Bone Marrow Transplant Complications
- +3 more
- Reiki
-
Ankara, None Selected, TurkeyNursemin Ünal
Jan 19, 2023
Immune Tolerance Trial in Palo Alto (Combined Deceased Donor Kidney and Hematopoietic Cell Transplants)
Enrolling by invitation
- Immune Tolerance
- Combined Deceased Donor Kidney and Hematopoietic Cell Transplants
-
Palo Alto, CaliforniaStanford University
May 6, 2022
B-cell NHL, CLL Trial (CARCIK-CD19)
Not yet recruiting
- B-cell NHL
- CLL
- CARCIK-CD19
- (no location specified)
May 19, 2023
PLT After Allogenic Hematopoietic Stem Cell Transplantation Trial (Avatrombopag, rhTPO)
Not yet recruiting
- PLT After Allogenic Hematopoietic Stem Cell Transplantation
- (no location specified)
Nov 21, 2021
Type 1 Diabetes Trial in United States (VC-01 Combination Product)
Active, not recruiting
- Type 1 Diabetes
- VC-01 Combination Product
-
Escondido, California
- +3 more
Feb 18, 2022
Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)
Not yet recruiting
- Stem Cell Transplant Complications
- Eltrombopag 25 MG Oral Tablet
- Thrombopoietin
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 17, 2022
Pre-engraftment Cytomegalovirus DNAemia
Completed
- CMV DNAemia Pre-engraftment
-
Valencia, SpainClinical University Hospital of Valencia
Nov 18, 2020
Kidney Transplant, Type 1 Diabetes Trial in Boston (Alpha 1-Antitrypsin, Islet Transplantation, Thymoglobulin)
Active, not recruiting
- Kidney Transplant
- Type 1 Diabetes
- Alpha 1-Antitrypsin
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital
Nov 15, 2021
Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected
No longer available
- Chronic Myeloid Leukemia
- +2 more
- G-CSF mobilized CD34+ selected cells for transplantation
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 28, 2022
Junctional Epidermolysis Bullosa Non-Herlitz Type Trial in Paris, Modena (Transplantation)
Recruiting
- Junctional Epidermolysis Bullosa Non-Herlitz Type
-
Paris, France
- +1 more
Aug 8, 2022
Hematologic Malignancies Trial in Minneapolis (Romiplostim)
Completed
- Hematologic Malignancies
-
Minneapolis, MinnesotaUniversity of Minnesota Masonic Cancer Center
Jun 5, 2021
Lymphoma Trial in Madison (drug, radiation, biological, procedure)
Completed
- Lymphoma
- Fludarabine Phosphate
- +9 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Dec 7, 2021
Non-Hodgkin's Lymphoma, B-Cell ALL, B-Cell CLL Trial in Houston (CD19.CAR-CD28Z T Cells - dose escalation 2, CD19.CAR-CD28Z T
Recruiting
- Non-Hodgkin's Lymphoma
- +2 more
- CD19.CAR-CD28Z T Cells - dose escalation 2
- CD19.CAR-CD28Z T Cells - dose escalation 1
-
Houston, Texas
- +1 more
Feb 10, 2022
HIV Trial in United States (SB-728mR-HSPC Infusion 3 days following busulfan conditioning)
Active, not recruiting
- HIV
- SB-728mR-HSPC Infusion 3 days following busulfan conditioning
-
Duarte, California
- +4 more
Mar 7, 2022
Poor Graft Function, Stem Cell Transplantation, GVHD Trial in Beijing (infusion of G-CSF mobilized peripheral harvest)
Completed
- Poor Graft Function
- +2 more
- infusion of G-CSF mobilized peripheral harvest
-
Beijing, Beijing, ChinaPeking University Institute of Hematology
Sep 23, 2020
Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,
Terminated
- Double Cord Blood Transplant
- +8 more
- TXA127 300 mcg/kg/day
- TXA127 1000 mcg/kg/day
-
Houston, TexasMD Anderson Cancer Center
Dec 7, 2020
SCID Trial in United States (Humanized anti-CD117 Monoclonal Antibody (JSP191))
Recruiting
- SCID
- Humanized anti-CD117 Monoclonal Antibody (JSP191)
-
Los Angeles, California
- +7 more
Nov 16, 2021
Acne Vulgaris Trial in Los Angeles (NB01)
Completed
- Acne Vulgaris
- NB01
-
Los Angeles, CaliforniaDermatology Research Associates
Jul 10, 2020
Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,
Recruiting
- Acute Erythroid Leukemia
- +10 more
- Fludarabine
- +5 more
-
San Francisco, California
- +5 more
Nov 1, 2022